← Leaderboards
Ann R Falsey
University Of Rochester
$14,447,817
Attributed
$26,443,446
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,443,446 · 5
By mechanism
UM1$20,238,010 · 1
R01$6,185,436 · 3
R13$20,000 · 1
Top collaborators
- Angela Ramona Branche17 shared
- Thomas J Mariani6 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Angela Ramona Branche$10,119,005
- Todd Jusko$2,559,418
- Thomas J Mariani$8,148,738
- Daniel Patrick Croft$1,201,404
- B. Paige Lawrence$23,471,485
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultRespiratoryInfectionVirusHospitalsAntibioticsPathogenImmune ResponseAntibiotic-Resistant OrganismPhysiciansGenetic TranscriptionDiagnosticLaboratoriesEnrollmentDesignVaccinesInfantScientistTrainingCommunitiesChildSamplingUnited States National Institutes Of HealthInfluenza
Grant awards (32)
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$865,920
UM1 · FY2025 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$932,430
UM1 · FY2024 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$1,026,345
UM1 · FY2023 · AI · contact PI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses$709,570
R01 · FY2023 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$132,523
UM1 · FY2023 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$2,736,516
UM1 · FY2022 · AI · contact PI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses$745,477
R01 · FY2022 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$587,361
UM1 · FY2022 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$506,940
UM1 · FY2022 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$490,470
UM1 · FY2022 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$3,197,781
UM1 · FY2021 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit(VTEU)-DMID 21-0012$1,242,949
UM1 · FY2021 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)-mRNA-1273-P204 Moderna Pediatric Study$1,144,400
UM1 · FY2021 · AI · contact PI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses$639,235
R01 · FY2021 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$601,546
UM1 · FY2021 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit(VTEU)- DMID-21-0004$554,098
UM1 · FY2021 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$244,250
UM1 · FY2021 · AI · contact PI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses$112,806
R01 · FY2021 · AI · contact PI
CoVPN - COVID Countermeasures$5,088,428
UM1 · FY2020 · AI · contact PI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses$761,271
R01 · FY2020 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$615,897
UM1 · FY2020 · AI · contact PI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)$270,156
UM1 · FY2020 · AI · contact PI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses$784,890
R01 · FY2019 · AI · contact PI
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics$423,110
R01 · FY2011 · AI · contact PI
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics$431,997
R01 · FY2010 · AI · contact PI
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics$421,740
R01 · FY2009 · AI · contact PI
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics$68,890
R01 · FY2009 · AI · contact PI
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics$426,714
R01 · FY2008 · AI · contact PI
Human Metapneumovirus Infection in Adults$213,886
R01 · FY2007 · AI · contact PI
Sixth International Respiratory Syncytial Virus Symposium$20,000
R13 · FY2007 · AI · contact PI
Human Metapneumovirus Infection in Adults$220,275
R01 · FY2006 · AI · contact PI
Human Metapneumovirus Infection in Adults$225,575
R01 · FY2005 · AI